{"entity":{"type":"insider","cik":"0001627642","url":"/insider/0001627642","json_url":"/insider/0001627642.json","name":"ZACCARDELLI DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":72,"n_filings":50,"first":"2015-01-07","last":"2025-08-05","span_basis":"filed_date"},"name_variants":[{"name":"ZACCARDELLI DAVID","source":"filing","n_filings":50,"first_seen":"2015-01-07","last_seen":"2025-08-05"}],"transactions":[{"id":4422101,"accession":"0001104659-25-074389","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-074389","line_url":"/filing/0001104659-25-074389#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208912.0,"shares_display":"208,912","price_per_share":13.1437,"price_display":"13.14","price_state":"stated","total_value":2745876.6544,"total_display":"2,745,876.65","total_whole":"2,745,877","shares_owned_after":13376144.0,"shares_owned_after_display":"13,376,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":5162588,"accession":"0001104659-25-059398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-059398","line_url":"/filing/0001104659-25-059398#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":11.4013,"price_display":"11.40","price_state":"stated","total_value":4560520.0,"total_display":"4,560,520.00","total_whole":"4,560,520","shares_owned_after":13190168.0,"shares_owned_after_display":"13,190,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-11","filed_date":"2025-06-13","scope":"insider"},{"id":4666388,"accession":"0001104659-25-054260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-054260","line_url":"/filing/0001104659-25-054260#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208696.0,"shares_display":"208,696","price_per_share":9.3322,"price_display":"9.33","price_state":"stated","total_value":1947592.8112,"total_display":"1,947,592.81","total_whole":"1,947,593","shares_owned_after":13590168.0,"shares_owned_after_display":"13,590,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-29","filed_date":"2025-05-29","scope":"insider"},{"id":4666383,"accession":"0001104659-25-054260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-054260","line_url":"/filing/0001104659-25-054260#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157704.0,"shares_display":"157,704","price_per_share":9.301,"price_display":"9.30","price_state":"stated","total_value":1466804.904,"total_display":"1,466,804.90","total_whole":"1,466,805","shares_owned_after":13798864.0,"shares_owned_after_display":"13,798,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-29","scope":"insider"},{"id":4666381,"accession":"0001104659-25-054260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-054260","line_url":"/filing/0001104659-25-054260#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33600.0,"shares_display":"33,600","price_per_share":9.5292,"price_display":"9.53","price_state":"stated","total_value":320181.12,"total_display":"320,181.12","total_whole":"320,181","shares_owned_after":13956568.0,"shares_owned_after_display":"13,956,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":4629894,"accession":"0001104659-25-044530","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-044530","line_url":"/filing/0001104659-25-044530#line-4","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":9.0938,"price_display":"9.09","price_state":"stated","total_value":3637520.0,"total_display":"3,637,520.00","total_whole":"3,637,520","shares_owned_after":13990168.0,"shares_owned_after_display":"13,990,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-05","scope":"insider"},{"id":4629890,"accession":"0001104659-25-044530","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-044530","line_url":"/filing/0001104659-25-044530","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187008.0,"shares_display":"187,008","price_per_share":8.9502,"price_display":"8.95","price_state":"stated","total_value":1673759.0016,"total_display":"1,673,759.00","total_whole":"1,673,759","shares_owned_after":14268904.0,"shares_owned_after_display":"14,268,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider","n_lines":2},{"id":4592612,"accession":"0001104659-25-043647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-043647","line_url":"/filing/0001104659-25-043647#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90360.0,"shares_display":"90,360","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":811432.8,"total_display":"811,432.80","total_whole":"811,433","shares_owned_after":14377176.0,"shares_owned_after_display":"14,377,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-29","filed_date":"2025-05-01","scope":"insider"},{"id":2108284,"accession":"0001104659-24-126372","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-126372","line_url":"/filing/0001104659-24-126372#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162800.0,"shares_display":"162,800","price_per_share":5.0086,"price_display":"5.01","price_state":"stated","total_value":815400.08,"total_display":"815,400.08","total_whole":"815,400","shares_owned_after":14204752.0,"shares_owned_after_display":"14,204,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-06","scope":"insider"},{"id":2108283,"accession":"0001104659-24-126372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-126372","line_url":"/filing/0001104659-24-126372#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":640264.0,"shares_display":"640,264","price_per_share":5.0061,"price_display":"5.01","price_state":"stated","total_value":3205225.6104,"total_display":"3,205,225.61","total_whole":"3,205,226","shares_owned_after":14367552.0,"shares_owned_after_display":"14,367,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-06","scope":"insider"},{"id":2108281,"accession":"0001104659-24-126372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-126372","line_url":"/filing/0001104659-24-126372#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67608.0,"shares_display":"67,608","price_per_share":5.0018,"price_display":"5.00","price_state":"stated","total_value":338161.6944,"total_display":"338,161.69","total_whole":"338,162","shares_owned_after":15007816.0,"shares_owned_after_display":"15,007,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2779661,"accession":"0001104659-24-124756","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-124756","line_url":"/filing/0001104659-24-124756#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":15075424.0,"shares_owned_after_display":"15,075,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-02","scope":"insider"},{"id":2779655,"accession":"0001104659-24-124756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-124756","line_url":"/filing/0001104659-24-124756#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98888.0,"shares_display":"98,888","price_per_share":5.006,"price_display":"5.01","price_state":"stated","total_value":495033.328,"total_display":"495,033.33","total_whole":"495,033","shares_owned_after":15078624.0,"shares_owned_after_display":"15,078,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-02","scope":"insider"},{"id":2779646,"accession":"0001104659-24-124756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-124756","line_url":"/filing/0001104659-24-124756#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23240.0,"shares_display":"23,240","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":116200.0,"total_display":"116,200.00","total_whole":"116,200","shares_owned_after":15177512.0,"shares_owned_after_display":"15,177,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-12-02","scope":"insider"},{"id":2306238,"accession":"0001104659-24-123210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-123210","line_url":"/filing/0001104659-24-123210#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":15200752.0,"shares_owned_after_display":"15,200,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-26","scope":"insider"},{"id":2779526,"accession":"0001104659-24-117794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-117794","line_url":"/filing/0001104659-24-117794#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":15202352.0,"shares_owned_after_display":"15,202,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2171409,"accession":"0001104659-24-114410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-114410","line_url":"/filing/0001104659-24-114410#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94144.0,"shares_display":"94,144","price_per_share":4.3918,"price_display":"4.39","price_state":"stated","total_value":413461.6192,"total_display":"413,461.62","total_whole":"413,462","shares_owned_after":15204752.0,"shares_owned_after_display":"15,204,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-05","scope":"insider"},{"id":2171405,"accession":"0001104659-24-114410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-114410","line_url":"/filing/0001104659-24-114410#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46888.0,"shares_display":"46,888","price_per_share":4.3763,"price_display":"4.38","price_state":"stated","total_value":205195.9544,"total_display":"205,195.95","total_whole":"205,196","shares_owned_after":15298896.0,"shares_owned_after_display":"15,298,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2837840,"accession":"0001104659-24-111566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-111566","line_url":"/filing/0001104659-24-111566#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":4.3758,"price_display":"4.38","price_state":"stated","total_value":21003.84,"total_display":"21,003.84","total_whole":"21,004","shares_owned_after":14591736.0,"shares_owned_after_display":"14,591,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-25","filed_date":"2024-10-25","scope":"insider"},{"id":2837834,"accession":"0001104659-24-111566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-111566","line_url":"/filing/0001104659-24-111566#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140000.0,"shares_display":"140,000","price_per_share":4.3773,"price_display":"4.38","price_state":"stated","total_value":612822.0,"total_display":"612,822.00","total_whole":"612,822","shares_owned_after":14596536.0,"shares_owned_after_display":"14,596,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-24","filed_date":"2024-10-25","scope":"insider"},{"id":2837828,"accession":"0001104659-24-111566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-111566","line_url":"/filing/0001104659-24-111566#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16.0,"shares_display":"16","price_per_share":4.375,"price_display":"4.38","price_state":"stated","total_value":70.0,"total_display":"70.00","total_whole":"70","shares_owned_after":14736536.0,"shares_owned_after_display":"14,736,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-25","scope":"insider"},{"id":2600841,"accession":"0001104659-24-110659","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-110659","line_url":"/filing/0001104659-24-110659#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157912.0,"shares_display":"157,912","price_per_share":4.3868,"price_display":"4.39","price_state":"stated","total_value":692728.3616,"total_display":"692,728.36","total_whole":"692,728","shares_owned_after":14736552.0,"shares_owned_after_display":"14,736,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-22","filed_date":"2024-10-22","scope":"insider"},{"id":2600833,"accession":"0001104659-24-110659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-110659","line_url":"/filing/0001104659-24-110659#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110456.0,"shares_display":"110,456","price_per_share":4.3796,"price_display":"4.38","price_state":"stated","total_value":483753.0976,"total_display":"483,753.10","total_whole":"483,753","shares_owned_after":14894464.0,"shares_owned_after_display":"14,894,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-21","filed_date":"2024-10-22","scope":"insider"},{"id":2600826,"accession":"0001104659-24-110659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-110659","line_url":"/filing/0001104659-24-110659#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":245784.0,"shares_display":"245,784","price_per_share":4.3809,"price_display":"4.38","price_state":"stated","total_value":1076755.1256,"total_display":"1,076,755.13","total_whole":"1,076,755","shares_owned_after":15004920.0,"shares_owned_after_display":"15,004,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":2472112,"accession":"0001104659-24-099794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-099794","line_url":"/filing/0001104659-24-099794#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":3.7572,"price_display":"3.76","price_state":"stated","total_value":2254320.0,"total_display":"2,254,320.00","total_whole":"2,254,320","shares_owned_after":15250704.0,"shares_owned_after_display":"15,250,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":3118074,"accession":"0001104659-24-089644","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-089644","line_url":"/filing/0001104659-24-089644","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398400.0,"shares_display":"398,400","price_per_share":3.202010502008032,"price_display":"3.20","price_state":"stated","total_value":1275680.984,"total_display":"1,275,680.98","total_whole":"1,275,681","shares_owned_after":15858920.0,"shares_owned_after_display":"15,858,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-14","scope":"insider","n_lines":2},{"id":3118054,"accession":"0001104659-24-089644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-089644","line_url":"/filing/0001104659-24-089644#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":5008.0,"total_display":"5,008.00","total_whole":"5,008","shares_owned_after":16249104.0,"shares_owned_after_display":"16,249,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":7860691,"accession":"0001104659-23-088492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-088492","line_url":"/filing/0001104659-23-088492#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8616.0,"shares_display":"8,616","price_per_share":2.4679,"price_display":"2.47","price_state":"stated","total_value":21263.4264,"total_display":"21,263.43","total_whole":"21,263","shares_owned_after":16431800.0,"shares_owned_after_display":"16,431,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-07","scope":"insider"},{"id":7860688,"accession":"0001104659-23-088492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-088492","line_url":"/filing/0001104659-23-088492#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":2.4992,"price_display":"2.50","price_state":"stated","total_value":374880.0,"total_display":"374,880.00","total_whole":"374,880","shares_owned_after":16440416.0,"shares_owned_after_display":"16,440,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":7860685,"accession":"0001104659-23-088492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-088492","line_url":"/filing/0001104659-23-088492#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117272.0,"shares_display":"117,272","price_per_share":2.539,"price_display":"2.54","price_state":"stated","total_value":297753.608,"total_display":"297,753.61","total_whole":"297,754","shares_owned_after":16590416.0,"shares_owned_after_display":"16,590,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":8319463,"accession":"0001104659-23-087441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-087441","line_url":"/filing/0001104659-23-087441#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73704.0,"shares_display":"73,704","price_per_share":2.593,"price_display":"2.59","price_state":"stated","total_value":191114.472,"total_display":"191,114.47","total_whole":"191,114","shares_owned_after":16707688.0,"shares_owned_after_display":"16,707,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-03","scope":"insider"},{"id":8319460,"accession":"0001104659-23-087441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-087441","line_url":"/filing/0001104659-23-087441#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105944.0,"shares_display":"105,944","price_per_share":2.679,"price_display":"2.68","price_state":"stated","total_value":283823.976,"total_display":"283,823.98","total_whole":"283,824","shares_owned_after":16781392.0,"shares_owned_after_display":"16,781,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":7860466,"accession":"0001104659-23-055646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-055646","line_url":"/filing/0001104659-23-055646#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":455536.0,"shares_display":"455,536","price_per_share":2.5759,"price_display":"2.58","price_state":"stated","total_value":1173415.1824,"total_display":"1,173,415.18","total_whole":"1,173,415","shares_owned_after":16887336.0,"shares_owned_after_display":"16,887,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":7843780,"accession":"0001104659-23-010734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-010734","line_url":"/filing/0001104659-23-010734#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432928.0,"shares_display":"432,928","price_per_share":2.5572,"price_display":"2.56","price_state":"stated","total_value":1107083.4816,"total_display":"1,107,083.48","total_whole":"1,107,083","shares_owned_after":17342872.0,"shares_owned_after_display":"17,342,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":6537709,"accession":"0001104659-22-129085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-129085","line_url":"/filing/0001104659-22-129085#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":2.116,"price_display":"2.12","price_state":"stated","total_value":1269600.0,"total_display":"1,269,600.00","total_whole":"1,269,600","shares_owned_after":17775800.0,"shares_owned_after_display":"17,775,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6307811,"accession":"0001104659-22-114416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-114416","line_url":"/filing/0001104659-22-114416#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32904.0,"shares_display":"32,904","price_per_share":1.6726,"price_display":"1.67","price_state":"stated","total_value":55035.2304,"total_display":"55,035.23","total_whole":"55,035","shares_owned_after":18375800.0,"shares_owned_after_display":"18,375,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6537359,"accession":"0001104659-22-089568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-089568","line_url":"/filing/0001104659-22-089568#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":1050000.0,"total_display":"1,050,000.00","total_whole":"1,050,000","shares_owned_after":15263560.0,"shares_owned_after_display":"15,263,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-11","scope":"insider"},{"id":6125085,"accession":"0001104659-22-085630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-085630","line_url":"/filing/0001104659-22-085630#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32904.0,"shares_display":"32,904","price_per_share":0.6998,"price_display":"0.70","price_state":"stated","total_value":23026.2192,"total_display":"23,026.22","total_whole":"23,026","shares_owned_after":15863560.0,"shares_owned_after_display":"15,863,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6955535,"accession":"0001104659-22-056608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-056608","line_url":"/filing/0001104659-22-056608#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32904.0,"shares_display":"32,904","price_per_share":0.4956,"price_display":"0.50","price_state":"stated","total_value":16307.2224,"total_display":"16,307.22","total_whole":"16,307","shares_owned_after":16351328.0,"shares_owned_after_display":"16,351,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-05","scope":"insider"},{"id":6146855,"accession":"0001104659-22-011440","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-011440","line_url":"/filing/0001104659-22-011440#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52056.0,"shares_display":"52,056","price_per_share":0.7256,"price_display":"0.73","price_state":"stated","total_value":37771.8336,"total_display":"37,771.83","total_whole":"37,772","shares_owned_after":16839096.0,"shares_owned_after_display":"16,839,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-03","scope":"insider"},{"id":5052279,"accession":"0001104659-21-133857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-133857","line_url":"/filing/0001104659-21-133857#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52056.0,"shares_display":"52,056","price_per_share":0.6411,"price_display":"0.64","price_state":"stated","total_value":33373.1016,"total_display":"33,373.10","total_whole":"33,373","shares_owned_after":16845352.0,"shares_owned_after_display":"16,845,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":4948707,"accession":"0001104659-21-100281","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-100281","line_url":"/filing/0001104659-21-100281#line-3","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18400.0,"shares_display":"18,400","price_per_share":0.7432,"price_display":"0.74","price_state":"stated","total_value":13674.88,"total_display":"13,674.88","total_whole":"13,675","shares_owned_after":17369912.0,"shares_owned_after_display":"17,369,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-04","scope":"insider"},{"id":4948702,"accession":"0001104659-21-100281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-100281","line_url":"/filing/0001104659-21-100281#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":0.7631,"price_display":"0.76","price_state":"stated","total_value":12209.6,"total_display":"12,209.60","total_whole":"12,210","shares_owned_after":17388312.0,"shares_owned_after_display":"17,388,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-04","scope":"insider"},{"id":4410072,"accession":"0001104659-21-102403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-102403","line_url":"/filing/0001104659-21-102403#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17656.0,"shares_display":"17,656","price_per_share":0.7524,"price_display":"0.75","price_state":"stated","total_value":13284.3744,"total_display":"13,284.37","total_whole":"13,284","shares_owned_after":17352256.0,"shares_owned_after_display":"17,352,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-09","scope":"insider"},{"id":5247643,"accession":"0001104659-21-061710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-061710","line_url":"/filing/0001104659-21-061710#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52056.0,"shares_display":"52,056","price_per_share":0.8054,"price_display":"0.81","price_state":"stated","total_value":41925.9024,"total_display":"41,925.90","total_whole":"41,926","shares_owned_after":17859160.0,"shares_owned_after_display":"17,859,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-05","scope":"insider"},{"id":4947935,"accession":"0001104659-21-031699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-031699","line_url":"/filing/0001104659-21-031699#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43392.0,"shares_display":"43,392","price_per_share":1.1437,"price_display":"1.14","price_state":"stated","total_value":49627.4304,"total_display":"49,627.43","total_whole":"49,627","shares_owned_after":20050848.0,"shares_owned_after_display":"20,050,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":8747932,"accession":"0001562180-19-005059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005059","line_url":"/filing/0001562180-19-005059#line-1","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5275.0,"shares_display":"5,275","price_per_share":27.9,"price_display":"27.90","price_state":"stated","total_value":147172.5,"total_display":"147,172.50","total_whole":"147,173","shares_owned_after":76647.0,"shares_owned_after_display":"76,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-02","scope":"insider"},{"id":8702291,"accession":"0001209191-19-041095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-041095","line_url":"/filing/0001209191-19-041095#line-2","is_derivative":false,"issuer_cik":"0001627642","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001627642","owner_cik":"0001627642","owner_name":"ZACCARDELLI DAVID","owner_display_name":"ZACCARDELLI DAVID","owner_url":"/insider/0001627642","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5899.0,"shares_display":"5,899","price_per_share":15.73,"price_display":"15.73","price_state":"stated","total_value":92791.27,"total_display":"92,791.27","total_whole":"92,791","shares_owned_after":86473.0,"shares_owned_after_display":"86,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-03","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-02|8702291","ledger_fault":false,"count":{"value":72,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":70,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":72},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001657312","name":"Verona Pharma plc","url":"/issuer/0001657312","role":"Director, Officer (President and CEO)","n_filings":29,"first_seen":"2021-03-03","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals Inc.","url":"/issuer/0001685071","role":"Director, Officer (President & CEO)","n_filings":3,"first_seen":"2018-12-21","last_seen":"2019-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001461993","name":"MELINTA THERAPEUTICS, INC. /NEW/","url":"/issuer/0001461993","role":"Director","n_filings":1,"first_seen":"2018-05-31","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001082554","name":"UNITED THERAPEUTICS Corp","url":"/issuer/0001082554","role":"Officer (EVP & Chief Operating Officer)","n_filings":17,"first_seen":"2015-01-07","last_seen":"2015-04-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001627642","retrieved_at":"2026-08-22T09:25:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}